TABLE 2.

[18F]FDHT Radiation Dosimetry in Women with Breast Cancer at S0: Absorbed Dose in Target Organ at S0

Target organAbsorbed dose (mGy/MBq)
MeanSDSD (%)
Adrenals2.3E−021.3E−035%
Bone (endosteal cells)1.4E−021.6E−0311%
Bone marrow (red, active)2.1E−023.9E−0319%
Brain5.3E−036.8E−0413%
Breast tissue1.2E−023.0E−043%
Colon1.7E−026.5E−044%
Extrathoracic region8.0E−033.0E−044%
Gallbladder wall2.5E−021.7E−037%
Heart wall2.1E−021.2E−036%
Kidneys3.4E−023.8E−0311%
Liver3.7E−023.9E−0311%
Lung1.5E−021.8E−0312%
Lymphatic nodes1.6E−027.0E−050%
Muscle1.3E−021.8E−041%
Ovaries2.6E−022.0E−037%
Pancreas1.9E−026.9E−044%
Skin9.1E−031.7E−042%
Small intestine1.9E−027.0E−044%
Spleen2.4E−022.2E−039%
Stomach1.6E−026.4E−044%
Thymus1.4E−025.9E−044%
Thyroid1.2E−024.0E−043%
Urinary bladder wall7.4E−021.1E−0215%
Uterus3.8E−024.0E−0311%
Total body1.3E−021.5E−041%
Effective dose (mSv/MBq)2.0E−025.0E−042%